These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Landing's disease or generalized GM1 gangliosidosis type I. Apropos of 2 cases in siblings]. Ponet D; Saint-Jacques I; Boissière H Ann Pediatr (Paris); 1982 Dec; 29(10):691-700. PubMed ID: 6818886 [No Abstract] [Full Text] [Related]
3. [The use of loading tests with labeled GM1-ganglioside for differential diagnosis of GM1-gangliosidosis]. Akhunov VS; Krasnopol'skaia KD; Mirenburg TV Vopr Med Khim; 1989; 35(5):119-22. PubMed ID: 2515652 [TBL] [Abstract][Full Text] [Related]
4. GM1-Gangliosidosis: a molecular abnormality of acid beta-galactosidase in fibroblasts. Furuya T; Suzuki Y J Inherit Metab Dis; 1984; 7(3):145-6. PubMed ID: 6438402 [No Abstract] [Full Text] [Related]
5. Chronic GM1 gangliosidosis presenting as dystonia: II. Biochemical studies. Kobayashi T; Suzuki K Ann Neurol; 1981 May; 9(5):476-83. PubMed ID: 6791575 [TBL] [Abstract][Full Text] [Related]
6. A case of type 2 Gm1-gangliosidosis with long survival. Kikuchi K; Minami R; Kudoh T; Nakao T; Tsugawa S Brain Dev; 1982; 4(2):153-6. PubMed ID: 6807121 [TBL] [Abstract][Full Text] [Related]
7. [A case of gangliosidosis GM1 in an infant]. Kordyasz E; Woźniewicz B Pol Tyg Lek; 1988 May 2-9; 43(18-19):608-9. PubMed ID: 3138677 [No Abstract] [Full Text] [Related]
8. GM1 gangliosidosis: phenotypic variation in a single family. Farrell DF; Ochs U Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662 [TBL] [Abstract][Full Text] [Related]
10. [Clinical, ultrastructural and biochemical study of a case of GM1 type 2 gangliosidosis]. Mammelle JC; Vanier MT; Baraton G; Gilly J; Carrier H; Guichard Y; Richard A; Gilly R Arch Fr Pediatr; 1975 Dec; 32(10):925-39. PubMed ID: 821451 [TBL] [Abstract][Full Text] [Related]
12. Detection of generalised GM1-gangliosidosis. Wiederschain G Lancet; 1980 Apr; 1(8173):881-2. PubMed ID: 6103241 [No Abstract] [Full Text] [Related]
13. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis]. Vel'tishchev IuE; Kalaidzhieva LV Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628 [TBL] [Abstract][Full Text] [Related]
14. Clinical course of GM1 gangliosidoses. Kohlschütter A Neuropediatrics; 1984 Sep; 15 Suppl():71-3. PubMed ID: 6443743 [TBL] [Abstract][Full Text] [Related]
15. GM3 gangliosidosis: a novel human sphingolipodystrophy. Maclaren NK; Max SR; Cornblath M; Brady RO; Ozand PT; Campbell J; Rennels M; Mergner WJ; Garcia JH Pediatrics; 1976 Jan; 57(1):106-10. PubMed ID: 813179 [TBL] [Abstract][Full Text] [Related]
16. Neurophysiological investigations in GM1 and GM2 gangliosidoses. Pampiglione G; Harden A Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798 [TBL] [Abstract][Full Text] [Related]
17. An explanation for variations in the clinical and biochemical symptoms of lysosomal-enzyme deficiency diseases such as GM1 gangliosidosis [proceedings]. Cheetham PS Biochem Soc Trans; 1979 Oct; 7(5):980-2. PubMed ID: 116891 [No Abstract] [Full Text] [Related]
18. Gmi-gangliosidosis. A variant with high activity of hepatic neutral beta-galactosidase. Suzuki Y; Hayakawa T; Yazaki M; Hiratani Y Eur J Pediatr; 1976 Jun; 122(3):177-86. PubMed ID: 819272 [TBL] [Abstract][Full Text] [Related]
20. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses. Kohyama M; Yabuki A; Ochiai K; Nakamoto Y; Uchida K; Hasegawa D; Takahashi K; Kawaguchi H; Tsuboi M; Yamato O BMC Vet Res; 2016 Mar; 12():67. PubMed ID: 27036194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]